Teva Pharmaceutical Industries Ltd
—- Market cap
- —
- Debt
- +$0.00
- Cash
- −$0.00
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: Teva Pharmaceutical Industries Ltd stock price vs WDAY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WDAY's multiple
Needs EPS (TTM), WDAY P/E.
Implied fair value · at Teva Pharmaceutical Industries Ltd's multiple
Needs Teva Pharmaceutical Industries Ltd P/E.
Engine logicTeva Pharmaceutical Industries Ltdvalued onWDAY’smultiple
Metric by metric
Price unavailable
Price unavailable
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Teva Pharmaceutical Industries Ltd Latest annual filing · WDAY FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
TEVA PHARMACEUTICAL INDUSTRIES LTD · implied price per share
Cash flow and years must be positive.
WORKDAY, INC. · implied price per share
Bear
$42.00
Base
$49.41
Bull
$56.82
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Teva Pharmaceutical Industries Ltd · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
0.54x
Net debt / EBITDA
Leverage against operating earnings
—
-0.84x
Cash and equivalents
Liquid reserves on the balance sheet
—
$5.44B
Total debt
Interest-bearing obligations outstanding
—
$4.21B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Salesforce, Inc.
Teva Pharmaceutical Industries Ltd vs CRM
Oracle Corporation
Teva Pharmaceutical Industries Ltd vs ORCL
INTUIT INC.
Teva Pharmaceutical Industries Ltd vs INTU
AUTOMATIC DATA PROCESSING INC
Teva Pharmaceutical Industries Ltd vs ADP
Paycom Software, Inc.
Teva Pharmaceutical Industries Ltd vs PAYC
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.